(Q37227488)

19 August 2017

Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone (English)

1 reference

19 August 2017

0 references

1

Janice C Froehlich

1 reference

19 August 2017

Brett J Hausauer

2

1 reference

PMC publication ID

3795831

19 August 2017

Dennis D Rasmussen

series ordinal

3

1 reference

19 August 2017

22 July 2013

1 reference

Alcoholism: Clinical and Experimental Research

19 August 2017

1 reference

19 August 2017

37

1 reference

19 August 2017

10

1 reference

19 August 2017

1763-1770

1 reference

Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Advances in the use of naltrexone: an integration of preclinical and clinical findings

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Drug synergism: its detection and applications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Adverse effects of oral naltrexone: analysis of data from two clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Animal models for the study of alcoholism: utility of selected lines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Progress toward a voluntary oral consumption model of alcoholism

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Recent developments in alcoholism:opioid peptides.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Opioid involvement in alcohol drinking

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Selective breeding for alcohol preference and associated responses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Effect of naltrexone on alcohol "high" in alcoholics.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Aversive effects of naltrexone in subjects not dependent on opiates

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

What aspects of human alcohol use disorders can be modeled using selectively bred rat lines?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Effects of α1-adrenoceptors and muscarinic cholinoceptors on water intake in rats

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Preclinical and clinical studies on naltrexone: what have they taught each other?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Simple designs and model-free tests for synergy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3795831

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FACER.12148

Role of alpha 1 adrenergic receptors in water balance in the rat

21 January 2018

1 reference

12 December 2020

Estimation of area under the curve for drugs subject to enterohepatic cycling

1 reference

12 December 2020

Naltrexone and dysphoria: a double-blind placebo controlled trial

1 reference

12 December 2020

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

12 December 2020

Salt-sensitive hypertension caused by long-term alpha-adrenergic blockade in the rat

1 reference

12 December 2020

Antinociception induced by simultaneous intrathecal and intraperitoneal administration of low doses of morphine

1 reference

12 December 2020

EFFICIENT DESIGNS FOR STUDYING SYNERGISTIC DRUG COMBINATIONS

1 reference

12 December 2020

The action of acetylcholine on the nictitating membrane of the spinal cat

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves

1 reference

12 December 2020

Identifiers

DOI

10.1111/ACER.12148

1 reference

19 August 2017

1 reference

PMC publication ID

3795831

19 August 2017

PubMed publication ID

23875623

1 reference

PMC publication ID

3795831